Free Trial

Recursion Pharmaceuticals (RXRX) SEC Filings & 10K Form

Recursion Pharmaceuticals logo
$4.66 -0.04 (-0.85%)
Closing price 09/2/2025 04:00 PM Eastern
Extended Trading
$4.70 +0.04 (+0.97%)
As of 08:53 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Recursion Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/29/2025
3:26 PM
Recursion Pharmaceuticals (Filer)
Form 424B7
08/29/2025
3:28 PM
Recursion Pharmaceuticals (Filer)
Form 8-K/A
08/28/2025
7:00 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2025
9:03 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2025
5:22 PM
Khan Najat (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2025
5:22 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2025
5:22 PM
Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2025
2:18 PM
Khan Najat (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2025
8:03 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025
2:31 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2025
5:33 AM
Recursion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2025
5:31 AM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2025
7:14 AM
Recursion Pharmaceuticals (Filer)
Form 424B7
07/08/2025
7:19 AM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2025
2:30 PM
Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
2:30 PM
Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
4:22 PM
Recursion Pharmaceuticals (Issuer)
Sun Elaine D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
4:22 PM
Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
4:23 PM
Bumpus Namandje (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
4:23 PM
Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
4:23 PM
HERSHBERG ROBERT (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
4:23 PM
Michor Franziska (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
4:23 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:32 PM
Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:22 PM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2025
5:04 AM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2025
4:26 PM
Recursion Pharmaceuticals (Filer)
Form 424B7
05/09/2025
4:27 PM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2025
5:07 AM
Recursion Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/05/2025
5:01 AM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2025
5:02 AM
Recursion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/03/2025
3:37 PM
Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:37 PM
Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:38 PM
Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
3:52 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2025
11:02 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
3:25 PM
Recursion Pharmaceuticals (Issuer)
Sun Elaine D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2025
3:26 PM
Bumpus Namandje (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2025
3:27 PM
Recursion Pharmaceuticals (Issuer)
Sun Elaine D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
3:27 PM
Bumpus Namandje (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
3:27 PM
Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)

A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the most famous companies in the world by 2030.tc pixel

Check this Out (The NEXT Magnificent Seven)
03/18/2025
7:01 AM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
3:16 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
10:55 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
9:13 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
6:26 AM
Recursion Pharmaceuticals (Filer)
Form 424B5
02/28/2025
5:31 AM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2025
5:33 AM
Recursion Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2025
3:42 PM
Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
3:42 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:41 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Recursion Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/14/2025
10:23 AM
ARK Investment Management LLC (Filed by)
Recursion Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/12/2025
4:07 PM
Recursion Pharmaceuticals (Filer)
Form S-3ASR
02/12/2025
8:32 AM
BAILLIE GIFFORD & CO (Filed by)
Recursion Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/06/2025
9:40 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
4:28 PM
BlackRock, Inc. (Filed by)
Recursion Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/05/2025
8:44 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2025
3:13 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
4:09 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
3:12 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/14/2025
3:21 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
4:26 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
8:04 AM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
9:58 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
9:30 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
5:02 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:02 PM
Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:02 PM
Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:24 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2024
3:16 PM
Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
5:49 PM
Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:05 PM
Recursion Pharmaceuticals (Filer)
Form 424B7
12/17/2024
4:06 PM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
3:48 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
4:46 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
9:29 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2024
9:32 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2024
3:40 PM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
6:02 PM
Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/27/2024
3:09 PM
Recursion Pharmaceuticals (Filer)
Form 8-K/A
11/26/2024
3:48 PM
Recursion Pharmaceuticals (Filer)
Form 8-K/A
11/22/2024
5:25 PM
Michor Franziska (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/22/2024
5:25 PM
Michor Franziska (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
6:11 AM
Recursion Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/20/2024
6:14 AM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2024
5:26 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
5:26 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
5:26 PM
Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
5:26 PM
Mauro David J (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
5:52 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
6:19 PM
Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
One tiny company just cracked Google’s $19B problem (Ad)

For decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. Then an MIT team cracked the code… dropping the cost from $63,000 to just 90 cents per gram. Now, one US-based factory is gearing up to supply the AI, aerospace, and EV industries with the one material they can’t continue to grow without. Only one company controls it, and its stock is still flying under Main Street’s radar.tc pixel

See why the race for supply has already started.
11/14/2024
6:19 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
3:34 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2024
9:11 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2024
8:22 AM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
3:57 PM
Recursion Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
1:48 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
9:34 AM
FMR LLC (Filed by)
Recursion Pharmaceuticals (Subject)
Form SC 13G/A
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
Recursion Pharmaceuticals (Subject)
Form SC 13G/A
11/06/2024
3:18 PM
Recursion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RXRX) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners